Literature DB >> 8827669

Prevalence of antibody to malignant catarrhal fever virus in wild and domestic ruminants by competitive-inhibition ELISA.

H Li1, D T Shen, D A Jessup, D P Knowles, J R Gorham, T Thorne, D O'Toole, T B Crawford.   

Abstract

A competitive-inhibition ELISA (CI-ELISA), based on a monoclonal antibody to an epitope conserved among malignant catarrhal fever virus (MCFV) strains of both wildebeest and sheep origin, was used to determine the prevalence of antibody to MCFV in selected domestic and wild ruminants, both free-ranging and captive, from the USA. We evaluated 2528 sera from 14 species between 1990 and 1995, including 80 pronghorn antelope (Antilocapra americana), 339 bighorn sheep (Ovis canadensis), 103 biston (Bison bison), 17 black-tailed deer (Odocoileus hemionus columbianus), 395 domestic cattle (Bos taurus), 291 domestic goats (Capra hircus), 680 domestic sheep (Ovis ammon), 323 elk (Cervus elaphus), 41 llamas (Lama glama), 21 mouflon sheep (Ovis musimon), 54 mountain goats (Oreamnos americanus), 101 mule deer (Odocoileus hemionus), 20 muskox (Ovibos moschatus), and 63 white-tailed deer (Odocoileus virginianus). A high seroprevalence (37 to 62%) was observed in domestic sheep, domestic goats, muskox, and some bighorn sheep populations. Seroprevalence in these species was generally age-related: a very low seroprevalence was present in these animals under one year of age. A low seroprevalence (2% to 13%) was found in clinically-susceptible species such as domestic cattle, deer, elk and bison, supporting the concept that significant numbers of non-lethal infections occur among clinically susceptible ruminants.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8827669     DOI: 10.7589/0090-3558-32.3.437

Source DB:  PubMed          Journal:  J Wildl Dis        ISSN: 0090-3558            Impact factor:   1.535


  8 in total

1.  Newly recognized herpesvirus causing malignant catarrhal fever in white-tailed deer (Odocoileus virginianus).

Authors:  H Li; N Dyer; J Keller; T B Crawford
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

2.  Characterization of Bison bison major histocompatibility complex class IIa haplotypes.

Authors:  Donald L Traul; Bharat Bhushan; Jennifer A Eldridge; Timothy B Crawford; Hong Li; Christopher J Davies
Journal:  Immunogenetics       Date:  2005-12-06       Impact factor: 2.846

3.  Transmission of ovine herpesvirus 2 in lambs.

Authors:  H Li; G Snowder; D O'Toole; T B Crawford
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

4.  Detection and multigenic characterization of a herpesvirus associated with malignant catarrhal fever in white-tailed deer (Odocoileus virginianus) from Missouri.

Authors:  Steven B Kleiboeker; Margaret A Miller; Susan K Schommer; Jose A Ramos-Vara; Magalie Boucher; Susan E Turnquist
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

5.  Malignant catarrhal fever-like disease in Barbary red deer (Cervus elaphus barbarus) naturally infected with a virus resembling alcelaphine herpesvirus 2.

Authors:  Robert Klieforth; Gabriel Maalouf; Ilse Stalis; Karen Terio; Donald Janssen; Mark Schrenzel
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

6.  Duration of protective immunity and antibody responses in cattle immunised against alcelaphine herpesvirus-1-induced malignant catarrhal fever.

Authors:  George C Russell; Julio Benavides; Dawn Grant; Helen Todd; David Deane; Ann Percival; Jackie Thomson; Maira Connelly; David M Haig
Journal:  Vet Res       Date:  2012-06-11       Impact factor: 3.683

Review 7.  Malignant catarrhal fever: understanding molecular diagnostics in context of epidemiology.

Authors:  Hong Li; Cristina W Cunha; Naomi S Taus
Journal:  Int J Mol Sci       Date:  2011-10-18       Impact factor: 5.923

8.  Seroprevalence of malignant catarrhal fever-related gammaherpesviruses in domestic ruminants in Turkey.

Authors:  K Yeşlbağ
Journal:  Trop Anim Health Prod       Date:  2007-06       Impact factor: 1.893

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.